0001604710-17-000003.txt : 20170405 0001604710-17-000003.hdr.sgml : 20170405 20170405171411 ACCESSION NUMBER: 0001604710-17-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 EFFECTIVENESS DATE: 20170405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Transplant Genomics Inc. CENTRAL INDEX KEY: 0001604710 IRS NUMBER: 462380447 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-284161 FILM NUMBER: 17743469 BUSINESS ADDRESS: STREET 1: 1501 BEACON STREET STREET 2: #1903 CITY: BROOKLINE STATE: MA ZIP: 02446 BUSINESS PHONE: 617-733-0757 MAIL ADDRESS: STREET 1: 1501 BEACON STREET STREET 2: #1903 CITY: BROOKLINE STATE: MA ZIP: 02446 D 1 primary_doc.xml X0707 D LIVE 0001604710 Transplant Genomics Inc. 905 S Main Street Suite 202 Mansfield MA MASSACHUSETTS 02048 508-337-6200 DELAWARE None None Corporation true 2013 Stanley Rose c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Director Michael Abecassis c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Director Roy First c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Darren Lee c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Peter Lewis c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Chris O'Connor c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Director Jay Venkatesan c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Director Other Decline to Disclose 06b false 2017-03-22 false true true false 0 Arcadia Securities, LLC None Arcadia Securities, LLC 50764 304 Tom Hunter Road Fort Lee NJ NEW JERSEY 07024 NY NEW YORK false 5525247 3169532 2355715 false 27 0 31502 true $16,522.46 of the Finders' Fee above is in the form of equity issued by Transplant Genomics Inc. and $1,543.54 of the Finders' Fee above is in the form of a warrant issued by Transplant Genomics Inc. 0 false Transplant Genomics Inc. /s/ Stanley Rose Stanley Rose CEO 2017-04-03